Literature DB >> 26011679

Usefulness of sonourethrography for penile abscess as a result of xanthogranulomatous granuloma in the corpus cavernosum of an adult: A case report.

Tomonori Minagawa1, Haruaki Kato1, Teruyuki Ogawa1, Takeshi Uehara2, Osamu Ishizuka1.   

Abstract

A 75-year-old man presented with a 4-month history of a swollen and painful penis. Computed tomography showed a round-shaped mass measuring 3 × 2 cm in the corpus cavernosum. Percutaneous drainage of the penile mass was carried out and a course of antibiotics was prescribed. Viral, fungal and selective bacterial cultures were negative. Total penectomy and urethroperineal fistula formation were carried out because of penile pain. Histopathological diagnosis was xanthogranulomatous granuloma of the corpus cavernosum. Before surgery, sonourethrography was carried out under general anesthesia. Sonourethrography is an infrequently used modality to observe the male urethra under urinary micturition or injection of saline. We previously reported modified sonourethrography with retrograde jelly injection. In the present case, sonourethrography successfully showed the damaged and deformed urethra including the abscess cavity and fistula. Although xanthogranulomatous granuloma is rare, the findings reported here showed the usefulness of sonourethrography for morphological evaluation of the male urethra.
© 2015 The Japanese Urological Association.

Entities:  

Keywords:  corpus cavernosum; sonourethrography; ultrasonography; urethra; xanthogranulomatous granuloma

Mesh:

Substances:

Year:  2015        PMID: 26011679     DOI: 10.1111/iju.12816

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  1 in total

1.  Modified sonourethrography assists urethral catheterization.

Authors:  Tomonori Minagawa; Toshiro Suzuki; Takahisa Domen; Hitoshi Yokoyama; Masakuni Ishikawa; Shiro Hirakata; Takashi Nagai; Masaki Nakazawa; Teruyuki Ogawa; Osamu Ishizuka
Journal:  J Med Ultrason (2001)       Date:  2016-02-05       Impact factor: 1.314

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.